Goldman Sachs Group set a €79.00 ($91.86) price target on Sanofi (EPA:SAN) in a research report report published on Thursday, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.
SAN has been the subject of several other research reports. JPMorgan Chase & Co. set a €81.00 ($94.19) target price on shares of Sanofi and gave the stock a neutral rating in a research note on Monday, April 29th. HSBC set a €82.00 ($95.35) target price on shares of Sanofi and gave the stock a neutral rating in a research note on Tuesday, June 11th. Deutsche Bank set a €93.00 ($108.14) target price on shares of Sanofi and gave the stock a buy rating in a research note on Friday, April 5th. Finally, UBS Group set a €79.00 ($91.86) price objective on shares of Sanofi and gave the company a neutral rating in a research note on Friday, April 26th. Six investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. The stock presently has an average rating of Buy and an average target price of €85.67 ($99.61).
Shares of SAN stock opened at €75.98 ($88.35) on Thursday. Sanofi has a 1-year low of €63.09 ($73.36) and a 1-year high of €92.97 ($108.10).
Sanofi provides therapeutic solutions. It offers Cerezyme and Cerdelga for Gaucher disease, Myozyme and Lumizyme for Pompe disease, Fabrazyme for Fabry disease, and Aldurazyme for mucopolysaccharidosis Type 1; Aubagio, an immunomodulatory; and Lemtrada, a monoclonal antibody to treat multiple sclerosis.
Featured Article: Technical Analysis
Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.